May 30, 2007 — Microfluidics Corp. of Newton, Mass., has unveiled standardized packages for its line of M-700 Microfluidizer materials processing machines, which produce nanoparticles. Designed specifically for the pharmaceutical and biotech industries, the packages promise superior results for pilot and production applications.

The processors are available in three different packages: Basic, Enhanced, and Aseptic. All three are available with a constant pressure option, which ensures that the product flows at constant pressure and velocity through the interaction chambers. Constant pressure is proven to eliminate pressure spikes, providing extremely uniform processing and permitting the system to operate more quietly and efficiently.

The processors can be used in FDA certified pharmaceutical production, and meet the standards such as cGMP 21 CFR.

The Enhanced and Aseptic versions feature a Yokogawa data acquisition (DAQ) station for continuous temperature, pressure and flow monitoring. The DAQ station promise easy and cost-effective recording and printing of digital testing data. All three packages include wash-down capabilities, and the Aseptic version offers additional Steam-in-Place (SIP) features that thoroughly clean and sanitize the system between batches or before storage.